Ameritas Investment Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.36K | Hold |
708
| – | – | ﹤0.01% | 3049 |
|
|
2025
Q1 | $9.33K | Hold |
708
| – | – | ﹤0.01% | 2842 |
|
|
2024
Q4 | $12.7K | Hold |
708
| – | – | ﹤0.01% | 2836 |
|
|
2024
Q3 | $11.4K | Hold |
708
| – | – | ﹤0.01% | 2880 |
|
|
2024
Q2 | $19.1K | Buy |
708
+388
| +121% | +$10.5K | ﹤0.01% | 2637 |
|
|
2024
Q1 | $6.23K | Hold |
320
| – | – | ﹤0.01% | 2917 |
|
|
2023
Q4 | $6.61K | Hold |
320
| – | – | ﹤0.01% | 2931 |
|
|
2023
Q3 | $10.2K | Hold |
320
| – | – | ﹤0.01% | 2834 |
|
|
2023
Q2 | $10.7K | Buy |
+320
| New | +$10.7K | ﹤0.01% | 2889 |
|
|
2022
Q2 | – | Sell |
-200
| Closed | -$7K | – | 3207 |
|
|
2022
Q1 | $7K | Hold |
200
| – | – | ﹤0.01% | 2897 |
|
|
2021
Q4 | $20K | Hold |
200
| – | – | ﹤0.01% | 2652 |
|
|
2021
Q3 | $25K | Hold |
200
| – | – | ﹤0.01% | 2582 |
|
|
2021
Q2 | $25K | Hold |
200
| – | – | ﹤0.01% | 2628 |
|
|
2021
Q1 | $27K | Hold |
200
| – | – | ﹤0.01% | 2433 |
|
|
2020
Q4 | $18K | Hold |
200
| – | – | ﹤0.01% | 2525 |
|
|
2020
Q3 | $15K | Hold |
200
| – | – | ﹤0.01% | 2533 |
|
|
2020
Q2 | $17K | Buy |
+200
| New | +$17K | ﹤0.01% | 2433 |
|
|
2019
Q2 | – | Sell |
-34
| Closed | -$2K | – | 3098 |
|
|
2019
Q1 | $2K | Hold |
34
| – | – | ﹤0.01% | 2952 |
|
|
2018
Q4 | $3K | Hold |
34
| – | – | ﹤0.01% | 2914 |
|
|
2018
Q3 | $16K | Hold |
34
| – | – | ﹤0.01% | 2626 |
|
|
2018
Q2 | $14K | Hold |
34
| – | – | ﹤0.01% | 2705 |
|
|
2018
Q1 | $10K | Hold |
34
| – | – | ﹤0.01% | 2732 |
|
|
2017
Q4 | $10K | Hold |
34
| – | – | ﹤0.01% | 2754 |
|
|
2017
Q3 | $18K | Hold |
34
| – | – | ﹤0.01% | 2488 |
|
|
2017
Q2 | $20K | Buy |
34
+20
| +143% | +$11.8K | ﹤0.01% | 2453 |
|
|
2017
Q1 | $6K | Buy |
+14
| New | +$6K | ﹤0.01% | 2815 |
|